Europe — EMA
Paosonelle (Drospirenone, Estradiol Hemihydrate)
Drospirenone, the active ingredient in Paosonelle, is a combined estrogen-progestogen hormone therapy presented as a tablet for oral use. It treats menopausal symptoms and provides contraception in women.
Request sourcing
What is Drospirenone, Estradiol Hemihydrate?
Drospirenone, the active ingredient in Paosonelle, is a combined estrogen-progestogen hormone therapy presented as a tablet for oral use. It treats menopausal symptoms and provides contraception in women. GNH USA supplies Paosonelle as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.
GNH USA supplies Paosonelle as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.
What is Drospirenone, Estradiol Hemihydrate used for?
Paosonelle is a combined hormone therapy that acts on the endocrine endocrine‑reproductive axis.
- Menopause symptom relief: Improves vasomotor symptoms such as hot‑flashes and night‑sleep - Contraception: Prevents ovulation and stabilises the endometrial lining, providing a reliable birth‑control method - Hormone‑replacement therapy: Restores estrogen levels to reduce bone loss and maintain urogenital health
What are the side effects of Drospirenone, Estradiol Hemihydrate?
Dro
